Amgen asked to participate on FDA EPO drug panel as cloud continues to loom over class
Amgen said it has been invited to participate on a May 10 FDA panel to review the use of anemia ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.